News Coverage 03.10.20 Share on Twitter Share on Facebook Share on LinkedIn PD1 Resistance with a Multi-Omic Approach Related Announcement Parker Institute for Cancer Immunotherapy Announces Appointment of Mark Veich as Chief Organizational Advancement Officer Announcement, Press Release Parker Institute for Cancer Immunotherapy Demonstrates Leadership and Showcases Latest Advances in Immunotherapy at SITC 2025 Annual Meeting Announcement, Press Release The Parker Institute for Cancer Immunotherapy Awards Over $1 Million to Five Early Stage Career Researchers Pushing the Boundaries of Cancer Science
Announcement Parker Institute for Cancer Immunotherapy Announces Appointment of Mark Veich as Chief Organizational Advancement Officer
Announcement, Press Release Parker Institute for Cancer Immunotherapy Demonstrates Leadership and Showcases Latest Advances in Immunotherapy at SITC 2025 Annual Meeting
Announcement, Press Release The Parker Institute for Cancer Immunotherapy Awards Over $1 Million to Five Early Stage Career Researchers Pushing the Boundaries of Cancer Science